« ORAHS2010 Conference: University Of Genova-School Of Economics | Main | Behavioral and Experimental Economics, Food and Health »
July 19, 2010
Health Economics from Theory to Practice: informing related decisions of Reimbursement, Research & Regulation
Location: Adelaide, South Australia
Dates: 19-21 July 2010
Presented by:
Professor Andrew Willan and Professor Simon Eckermann
With guest presenter:
Suitable for:
Evaluators of health technology assessment, health economists, pharmaco-economists, applied micro-economists, decision and policy makers and clinicians and researchers undertaking economic studies in clinical trials.
“The content is perfect, the interaction with teachers very good. Fantastic course!” Oxford course delegate, 2009
Numbers are strictly limited. Earlybird booking discount available.
Following a 5-star rating from the 2009 workshop conducted at the University of Oxford, UK, this popular course returns to Australia in 2010.
The course is based on internationally recognised methods as published by Professors Willan and Eckermann for optimal decision making in research design, health technology assessment (HTA) and practice and the book “Statistical Analysis of Cost-Effectiveness Data” by Professors Willan and Briggs.
At the conclusion of the course, participants will have learnt the principles and practical methods to:
1) Apply health economic methods to undertake robust health technology assessment and translate evidence (Willan and Briggs, 2006; Eckermann, Briggs and Willan, 2008; Eckermann, Coory and Willan, 2009);
2) Design research and grants to inform policy relevant decision making (Willan and Pinto, 2005; Eckermann and Willan, 2007, 2008a, 2008b, 2009; Willan, 2007, 2008; Willan and Kowgier, 2008; Willan and Eckermann, 2009);
3) Undertake performance and technology assessment in practice consistent with the principles of maximising net benefit underlying evidence based medicine (Eckermann, 2004; Eckermann, Briggs and Willan, 2008; Eckermann and Coelli, 2008).
Course materials provided include a comprehensive manual with tutorials and electronic templates in Microsoft(R) Excel to enable application of the methods in practice.
The workshop format is seminar and tutorial based presenting from first principles methods for optimal decision making, demonstrating the importance of considering each of the above points and their interaction. Best current methods covered include:
Construction and interpretation of cost effectiveness acceptability (CEA) and expected net loss (ENL) curves and frontier and their interpretation;
Optimal trial research design allowing for real world decision context, including time, opportunity costs and option value of delay, VOI across jurisdictions and implementation;
Comparing efficiency of health care providers in practice consistent with maximising expected net benefit.
Since 2005, in excess of 170 participants from policy, epidemiological, clinical, statistics and health economic backgrounds have successfully undertaken the course, including researchers and policy makers from the UK, Canada, Australia, USA, Japan and Korea, the Pharmaceutical Benefits Advisory Committee (PBAC) (Australia) and PBAC economic sub-committee, industry analysts and decision makers.
Further details on the course presenters, background, aims, content and references as well as the venue are available at http://clinicalchange.flinders.edu.au/courses.html.
Enquiries and registration for the workshop can be directed to Vicki Preston (+61 (0)8 8275 2859 or vicki.preston@flinders.edu.au). Please note that availability is strictly limited to 25 participants.
